ES302369A1 - Metodo de preparacion de compuestos triciclicos. - Google Patents

Metodo de preparacion de compuestos triciclicos.

Info

Publication number
ES302369A1
ES302369A1 ES0302369A ES302369A ES302369A1 ES 302369 A1 ES302369 A1 ES 302369A1 ES 0302369 A ES0302369 A ES 0302369A ES 302369 A ES302369 A ES 302369A ES 302369 A1 ES302369 A1 ES 302369A1
Authority
ES
Spain
Prior art keywords
carbon atoms
reaction
alkyl
see formula
mono
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0302369A
Other languages
English (en)
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
EIDP Inc
Original Assignee
EI Du Pont de Nemours and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by EI Du Pont de Nemours and Co filed Critical EI Du Pont de Nemours and Co
Publication of ES302369A1 publication Critical patent/ES302369A1/es
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/02Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements
    • C07D295/027Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring
    • C07D295/03Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms containing only hydrogen and carbon atoms in addition to the ring hetero elements containing only one hetero ring with the ring nitrogen atoms directly attached to acyclic carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/29Saturated compounds containing keto groups bound to rings
    • C07C49/313Saturated compounds containing keto groups bound to rings polycyclic
    • C07C49/323Saturated compounds containing keto groups bound to rings polycyclic having keto groups bound to condensed ring systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2603/00Systems containing at least three condensed rings
    • C07C2603/56Ring systems containing bridged rings
    • C07C2603/58Ring systems containing bridged rings containing three rings
    • C07C2603/70Ring systems containing bridged rings containing three rings containing only six-membered rings
    • C07C2603/74Adamantanes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ES0302369A 1963-07-24 1964-07-23 Metodo de preparacion de compuestos triciclicos. Expired ES302369A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US29723363A 1963-07-24 1963-07-24
US376259A US3352912A (en) 1963-07-24 1964-06-18 Adamantanes and tricyclo[4. 3. 1. 1 3.8] undecanes

Publications (1)

Publication Number Publication Date
ES302369A1 true ES302369A1 (es) 1965-03-16

Family

ID=26970055

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0302369A Expired ES302369A1 (es) 1963-07-24 1964-07-23 Metodo de preparacion de compuestos triciclicos.

Country Status (14)

Country Link
US (1) US3352912A (de)
AT (1) AT279581B (de)
BE (1) BE650919A (de)
BR (1) BR6460975D0 (de)
CH (2) CH476673A (de)
DE (3) DE1793207A1 (de)
DK (3) DK112027B (de)
ES (1) ES302369A1 (de)
FI (3) FI42322B (de)
FR (1) FR1572956A (de)
GB (1) GB1069563A (de)
IL (1) IL21753A (de)
NL (2) NL6408505A (de)
SE (3) SE320363B (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3449422A (en) * 1966-02-09 1969-06-10 Smithkline Corp Pentacycloundecane amines
DE1294371B (de) * 1966-12-21 1969-05-08 Penicillin Ges Dauelsberg & Co Verfahren zur Herstellung von 1-Aminoadamantan und dessen N-Alkyl- bzw. N-Cyclohexylderivaten
US3489802A (en) * 1967-01-23 1970-01-13 Du Pont Preparation of alpha-methyl-1-adamantane-methylamine and alpha,4 - dimethyl - 1 - bicyclo(2,2,2)octane methylamine
NL6900004A (de) * 1969-01-02 1970-07-06
US3682922A (en) * 1969-01-16 1972-08-08 Searle & Co N-acyl-n-{8 (n{40 ,n{40 -disubstituted amino)-alkyl{9 -1-adamantylmethylamines
JPS4828903B1 (de) * 1969-07-19 1973-09-05
US3624086A (en) * 1969-11-10 1971-11-30 Searle & Co Adamantanecarboxamidoalkanoic acid amides
US3852339A (en) * 1970-06-15 1974-12-03 Squibb & Sons Inc Aminoalkoxyphenylurea derivatives
US3879400A (en) * 1973-11-16 1975-04-22 Upjohn Co 1-Lower alkyl-(1-adamantylmethyl)piperidines and process for their preparation
JPS5346950A (en) * 1976-10-12 1978-04-27 Kao Corp (54)1-acetylaminotricyclo(4,3,1,12,5)undecane and its preparation
US4351847A (en) * 1981-06-26 1982-09-28 Pennwalt Corporation Antiviral alpha, alpha-dialkyl adamantylethylamines
US4551552A (en) * 1984-05-23 1985-11-05 E. I. Du Pont De Nemours And Company Process for preparing rimantadine
US4751245A (en) * 1986-06-25 1988-06-14 E. R. Squibb & Sons, Inc. Antifungal derivatives of N-(6,6-dimethyl-2-hepten-4-ynyl)-1-naphthalenemethanamine and method of using same
US5576355A (en) * 1993-06-04 1996-11-19 Mobil Oil Corp. Diamondoid derivatives for pharmaceutical use
US5684024A (en) * 1996-01-25 1997-11-04 Viropharma Incorporated Pyrazole dimers compositions and methods for treating influenza
US5821243A (en) 1996-07-22 1998-10-13 Viropharma Incorporated Compounds compositions and methods for treating influenza
ES2175614T3 (es) * 1997-04-10 2002-11-16 Pfizer Derivados fluorosustituidos de adamantano.
GB0013737D0 (en) 2000-06-07 2000-07-26 Astrazeneca Ab Novel compounds
WO2003079972A2 (en) 2002-02-22 2003-10-02 New River Parmaceuticals Inc. Active agent delivery systems and methods for protecting and administering active agents
WO2003004461A1 (en) * 2001-07-02 2003-01-16 Schering Corporation Drugs for treating viral infections
SE0103836D0 (sv) * 2001-11-16 2001-11-16 Astrazeneca Ab Novel compounds
WO2004056744A1 (en) * 2002-12-23 2004-07-08 Janssen Pharmaceutica N.V. Adamantyl acetamides as hydroxysteroid dehydrogenase inhibitors
SE0300480D0 (sv) 2003-02-21 2003-02-21 Astrazeneca Ab Novel compounds
GB0312609D0 (en) 2003-06-02 2003-07-09 Astrazeneca Ab Novel compounds
RU2447060C2 (ru) * 2005-06-17 2012-04-10 Эпоуджи Биотекнолоджи Корпорейшн Ингибиторы сфингозинкиназы
AR057623A1 (es) 2005-11-28 2007-12-05 Omega Bio Pharma H K Ltd Materiales y metodos para el tratamiento de las infecciones virales
PE20091225A1 (es) 2007-03-22 2009-09-16 Astrazeneca Ab Derivados de quinolina como antagonistas del receptor p2x7
PE20091036A1 (es) 2007-11-30 2009-08-15 Astrazeneca Ab Derivado de quinolina como antagonista del receptor p2x7
JP2015536940A (ja) 2012-10-29 2015-12-24 シプラ・リミテッド 抗ウイルス性ホスホネート類似体及びその製造方法
CA2930085C (en) * 2013-12-09 2021-11-02 Unilever Plc Process of making adamantanamides
US10583171B2 (en) 2015-11-30 2020-03-10 INSERM (Institut National de la Santé et de la Recherche Médicale) NMDAR antagonists for the treatment of diseases associated with angiogenesis
US11548893B2 (en) 2017-07-15 2023-01-10 Arisan Therapeutics Inc. Enantiomerically pure adamantane carboxamides for the treatment of filovirus infection

Also Published As

Publication number Publication date
DE1792295B1 (de) 1971-05-27
DK114769B (da) 1969-08-04
NL6408505A (de) 1965-01-25
BE650919A (de) 1964-11-16
AT279581B (de) 1970-03-10
BR6460975D0 (pt) 1973-08-09
DK112027B (da) 1968-11-04
FI42211B (de) 1970-03-02
CH479535A (de) 1969-10-15
DE1468769B1 (de) 1972-06-29
US3352912A (en) 1967-11-14
NL7102097A (de) 1971-05-25
CH476673A (de) 1969-08-15
FI42548B (de) 1970-06-01
SE330693B (de) 1970-11-30
DE1793207A1 (de) 1972-03-30
FR1572956A (de) 1969-07-04
DE1793208A1 (de) 1972-04-06
FI42322B (de) 1970-03-31
DK114199B (da) 1969-06-09
IL21753A (en) 1968-01-25
SE321924B (de) 1970-03-23
GB1069563A (en) 1967-05-17
SE320363B (de) 1970-02-09

Similar Documents

Publication Publication Date Title
ES302369A1 (es) Metodo de preparacion de compuestos triciclicos.
ES333336A1 (es) Un metodo de preparar un compuesto derivado de isoquinoleina
ES288359A1 (es) Un procedimiento para preparar una gonadienona
ES316958A1 (es) Procedimiento para endurecer compuestos epoxidos.
ES274333A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano y de 1,5-benzodioxepano
ES278356A1 (es) Procedimiento para la preparación de compuestos de hidrazina sustituídos
ES284448A1 (es) Dispositivo de protección de los aisladores contra los arcos eléctricos
ES300273A1 (es) Un método para la preparación de un compuesto químico orgánico biológicamente activo
ES319942A1 (es) Procedimiento para la obtencion de 3 ',4',5'-trimetoxi-3-aminoacrilofenona.
ES307983A1 (es) Procedimiento para la preparacion de nuevas amidas de acido ariloxiacetico.
ES274332A1 (es) Procedimiento para la preparacion de nuevos compuestos de 1,4-benzodioxano
ES317862A1 (es) Metodo para la produccion de nuevas penicilinas.
ES309175A1 (es) Procedimiento para la preparacion de nuevas amidas del acido ariloxiacetico.
ES278787A1 (es) Procedimiento para la preparación de nuevos derivados de ciclohexano
ES305118A1 (es) Metodo de preparacion de un compuesto nitrofurado.
ES251429A1 (es) Procedimiento para la obtenciën de nuevos derivados de indol
ES272911A3 (es) Procedimiento para la producciën de nuevos aminoalcoholes
ES306669A1 (es) Procedimiento para la preparacion de derivados 4-amino-antipirinicos.
ES318677A1 (es) Procedimiento de fabricaciën de halogenuros amënico cuaternarios de alquil-graso de piridimetil
ES252685A2 (es) Un metodo de preparaciën de un compuesto de la fërmula:
ES320802A1 (es) Un procedimiento para la preparaciën de 2- (2'-tiazolin-2'- i1) -bencimidazoles
ES324130A1 (es) Procedimiento para la sintesis de nuevos compuestos de diepoxido.
ES218647A1 (es) Un procedimiento para preparar compuestos quimicos de valor terapeutico
ES244636A1 (es) Procedimiento para la preparaciën de diaminas bis-cuaternarias
ES320083A1 (es) Procedimiento de preparacion de los derivados de la difenilamina.